Literature DB >> 7696408

Transfusion with xenogeneic erythrocytes into SCID mice and their clearance from the circulation.

C Ishihara1, M Tsuji, K Hagiwara, K Hioki, J Arikawa, I Azuma.   

Abstract

We have previously demonstrated that the red blood cells (RBCs) in the blood circulation of SCID mice could be almost completely substituted with bovine RBCs by means of repeated transfusions. In the present study, transfusion experiments were carried out with RBCs from various animal species to investigate the ability of SCID mice to accept xenogeneic RBCs. Bovine (Bo), equine (Eq), human (Hu) and murine (Mu) RBCs were labeled with a fluorescent dye to trace their trafficking in the blood stream. Following the intravenous injection these RBCs were cleared from the circulation at various rates; the 1/100 reduction time in the labeled cell counts was 2 to 7 days, 4 to 7 hr and 1 to 2 hr with Bo-, Hu- and Eq-RBCs, respectively. In contrast, labeled Mu-RBCs from not only syngeneic but also allogeneic mouse strain were able to stay over 50 days. The difference in clearance rates was attributable to the difference in uptake of the RBCs by the splenic macrophages. The clearance rates of labeled RBCs were significantly decreased by co-transfusion with unlabeled RBCs of the same species, indicating that xenogeneic RBCs were recognized by the reticulo-endothelial system of SCID mice in a species-specific fashion. Furthermore, at least in the case of Hu-RBC, the complement component 3 may play a role in the Hu-RBC clearance in SCID mice since C3 deposition was observed on Hu-RBCs but not on Bo- and Eq-RBCs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696408     DOI: 10.1292/jvms.56.1149

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  8 in total

1.  Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice.

Authors:  A Saito-Ito; M Tsuji; Q Wei; S He; T Matsui; M Kohsaki; S Arai; T Kamiyama; K Hioki; C Ishihara
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.

Authors:  Rosemary Rochford; Colin Ohrt; Paul C Baresel; Brice Campo; Aruna Sampath; Alan J Magill; Babu L Tekwani; Larry A Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

3.  Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.

Authors:  Rahima Zennadi; Benjamin J Moeller; Erin J Whalen; Milena Batchvarova; Ke Xu; Siqing Shan; Martha Delahunty; Mark W Dewhirst; Marilyn J Telen
Journal:  Blood       Date:  2007-07-03       Impact factor: 22.113

4.  Serum from Theileria sergenti-infected cattle accelerates the clearance of bovine erythrocytes in SCID mice.

Authors:  K Hagiwara; M Tsuji; C Ishihara; M Tajima; T Kurosawa; K Takahashi
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

5.  Analysis of innate defences against Plasmodium falciparum in immunodeficient mice.

Authors:  Ludovic Arnold; Rajeev Kumar Tyagi; Pedro Mejia; Nico Van Rooijen; Jean-Louis Pérignon; Pierre Druilhe
Journal:  Malar J       Date:  2010-07-09       Impact factor: 2.979

6.  Irradiation Can Selectively Kill Tumor Cells while Preserving Erythrocyte Viability in a Co-Culture System.

Authors:  Ming Gong; Jin-Ting Yang; Yun-Qing Liu; Li-Hui Tang; Yin Wang; Lie-Ju Wang; Feng-Jiang Zhang; Min Yan
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

7.  In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies.

Authors:  Christiane Broichhausen; Paloma Riquelme; Norbert Ahrens; Anja K Wege; Gudrun E Koehl; Hans J Schlitt; Bernhard Banas; Fred Fändrich; Edward K Geissler; James A Hutchinson
Journal:  Mol Ther Methods Clin Dev       Date:  2014-07-16       Impact factor: 6.698

8.  Immunodeficient mice are better for modeling the transfusion of human blood components than wild-type mice.

Authors:  Sophia A Blessinger; Johnson Q Tran; Rachael P Jackman; Renata Gilfanova; Jacqueline Rittenhouse; Alan G Gutierrez; John W Heitman; Kelsey Hazegh; Tamir Kanias; Marcus O Muench
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.